CUSIP 75955J402COMRLMDQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
78 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Janus Henderson Group PLC | 7.27M | $35.04M | +7.27M | New |
| 2 | Squadron Capital Management LLC | 6.70M | $32.36M | +6.70M | New Position |
| 3 | Adage Capital Partners Gp, L.L.C. | 4.27M | $20.62M | +4.27M | New |
| 4 | Spruce Street Capital LP | 4.09M | $19.74M |
| +4.09M |
| New Position |
| 5 | Marshall Wace, LLP | 3.19M | $15.41M | +2.92M | Added |
| 6 | Ikarian Capital, LLC | 3.07M | $14.82M | +1.23M | Added |
| 7 | Orbimed Advisors LLC | 2.61M | $12.61M | +2.61M | New |
| 8 | Ameriprise Financial Inc | 1.92M | $9.27M | +1.92M | New |
| 9 | Driehaus Capital Management LLC | 1.88M | $9.08M | +1.14M | Added |
| 10 | Millennium Management LLC | 1.67M | $8.08M | +1.67M | New |
See every fund holding Relmada Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders